News
3d
MedPage Today on MSNFirst-in-Class Lupus Drug Aces Phase III TestBARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...
The Green Steel Market, valued at USD 7.4 billion in 2024, is expected to reach USD 19.4 billion by 2029, growing at a CAGR ...
United Commercial Bank (UCB) has launched the first open API-based banking system in Bangladesh. With this initiative, the bank will be able to provide modern, convenient, and technology-driven ...
Belgian pharmaceutical company UCB says it plans to invest $5bn in a US factory to avoid President Trump’s tariffs on the EU.
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented ...
United Commercial Bank PLC (UCB) has launched a microservices-based open API banking platform in Bangladesh following an ...
UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...
Amid the threat of pharmaceutical tariffs from President Donald Trump, recent months have seen multibillion-dollar U.S.
Belgium’s largest drugmaker UCB has announced plans for a significant investment in a new, state-of-the-art biologics ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...
Ultimately, Stoke Therapeutics is that classic “intriguing biotech” --hurdling to one of those proverbial “moments of truth” ...
Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results